Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,511 Anemia
clinical trials

Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Michigan city, IN
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Munster, IN
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
National City, CA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Hampton, VA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Prescott, AZ
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 10/10/2017
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Hemophilia A Clinical Trial
BAX 855 Previously Untreated Patient (PUP)
Status: Enrolling, Phase III
Updated: 4/19/2018
Bleeding and Clotting Dis.Inst.
mi
from
Peoria, IL
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke University Heart Failure Research
mi
from
Durham, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Monmouth Cardiology Associates, LLC
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Heart & Vascular Institute of Hunterdon
mi
from
Flemington, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
North Texas Research Associates
mi
from
McKinney, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Riverside Cardiology Specialists
mi
from
Newport News, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Misal Khan, MD
mi
from
Panama City, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Pasadena Clinical Research
mi
from
Pasadena, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Broward Research Center
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Avanza Medical Research Center
mi
from
Pensacola, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Professional Health Care of Pinellas
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Beacon Medical Group Advanced Cardiovascular Specialists
mi
from
South Bend, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Wichita Falls Heart Clinic
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Tarzana, CA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors
Status: Enrolling, Phase
Updated: 3/26/2018
Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia
mi
from
Seattle, WA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ
Status: Enrolling, Phase
Updated: 12/31/1969
Fundación de Hemofilia de Salta
mi
from
Salta,
Click here to add this to my saved trials
Anemia, Hemolytic, Autoimmune Clinical Trial
A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)
Status: Enrolling, Phase I
Updated: 3/13/2018
University of California San Francisco - Outpatient Hematology Clinic/Infusion Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Alhambra, CA
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Clinical Trial
Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Westlake Village, CA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Dose-Ranging Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 in Subjects With Severe Hemophilia A
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Emory University, Dept. of Hematology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
iCanCope With Sickle Cell Pain
Status: Enrolling
Updated: 4/28/2018
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
UNC Hemophilia and Thrombosis Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California San Diego, Hematology and Oncology, Hemophilia &Thrombosis Treatment Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Myocardial Ischemia and Transfusion
Status: Enrolling, Phase III
Updated: 12/31/1969
NYP Brooklyn Methodist
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Myocardial Ischemia and Transfusion
Status: Enrolling, Phase III
Updated: 12/31/1969
PENN Presbyterian Medical Cente
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Akron, OH
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Akron, OH
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Status: Enrolling, Phase III
Updated: 12/31/1969
UF Shands Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Davis Hemophilia Treatment Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
Status: Enrolling, Phase II
Updated: 12/31/1969
East Carolina University East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mid Florida Hematology and Oncology Center
mi
from
Orange City, FL
Click here to add this to my saved trials
Hematology, Orthopedics / Podiatry Clinical Trial
Ultrasonography in Hemophilic Joint Disease and Serum Markers
Status: Enrolling, Phase
Updated: 4/4/2018
Feinstein Institute of Medical Research Northwell Health
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Portsmouth, NH
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry: A Nested Study Within an Existing Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Yale Hemophilia Treatment Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alabama at Birmingham; Pediatric Nephrology
mi
from
Birmingham, AL
Click here to add this to my saved trials
Iron Deficiency Anemia Clinical Trial
Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
Status: Enrolling, Phase III
Updated: 12/31/1969
International Research Partners, LLC.
mi
from
Doral, FL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Heidelberg,
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Barcelona,
Click here to add this to my saved trials
Hematology Clinical Trial
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Efficacy and Safety Study of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in ESA Naïve Subjects Who Require Red Blood Cell Transfusions
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Florida Cancer Specialists PAN
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Status: Enrolling, Phase II
Updated: 12/31/1969
El Paso Kidney Specialists, PA
mi
from
El Paso, TX
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Status: Enrolling, Phase II
Updated: 12/31/1969
International Physicians Research
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Status: Enrolling, Phase II
Updated: 12/31/1969
Milwaukee Nephrologists, SC
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Hemophilia Outreach Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Indiana Hemophilia and Thrombosis Center (IHTC)
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Maine Hemophilia and Thrombosis Center
mi
from
Scarborough, ME
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University/St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology Clinical Trial
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical University of South Carolina Lifespan Comprehensive Sickle Cell Clinic
mi
from
Charleston, SC
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Maryland Medical System Investigational Pharmacy
mi
from
Baltimore, MD
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Cincinnati Medical Center/Research Office
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Royal Alexandra Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
UF Health Davis Cancer Pavillion and Shands Med Plaza
mi
from
Gainesville, FL
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hermann - TMC Investigational Drugs, IDS Pharmacy
mi
from
Houston, TX
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Children´s Hospital - Investigational Pharmacy
mi
from
Houston, TX
Click here to add this to my saved trials
Anemia, Sickle Cell Clinical Trial
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Louisville Physicians Pediatric Hematology Oncology
mi
from
Louisville, KY
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Hermann Hospital, Texas Medical Center - Clinical Research Unit (CRU)
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Arkansas Children's Hospital Research Pharmacy
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Commonwealth University Clinical Research Services Unit
mi
from
Richmond, VA
Click here to add this to my saved trials
Hematology, Musculoskeletal Clinical Trial
Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Barnes-Jewish Hospital Department of Pharmacy
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Platelet Function in Patients With Hemophilia A
Status: Enrolling, Phase
Updated: 12/31/1969
Boston Children's Hospital, Boston Hemophilia Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Open Label Extension Study for the Long-term Efficacy and Safety of FG-4592 in Dialysis and Non-dialysis Chronic Kidney Disease Patients
Status: Enrolling, Phase II, III
Updated: 4/14/2016
Mountain Kidney & HTN Associates, PA
mi
from
Asheville, NC
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Alexandria, VA
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Berlin, NJ
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Hematology, Nephrology / Urology Clinical Trial
Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator Site
mi
from
Denison, TX
Click here to add this to my saved trials
1 … 14 15 16 17 18 19 20 21 22 23 24 25